Menu
Back to Archived Journals » Hypoxia » Volume 5
Hypoxia ceased publishing in January 2023. All articles that have been published in Hypoxia will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Hypoxia
ISSN: 2324-1128
- View all (65)
- Volume 8, 2020 (1)
- Volume 7, 2019 (8)
- Volume 6, 2018 (5)
- Volume 5, 2017 (8)
- Volume 4, 2016 (15)
- Volume 3, 2015 (9)
- Volume 2, 2014 (16)
- Volume 1, 2013 (3)
Archive: Volume 5, 2017
Respiratory muscle dysfunction in animal models of hypoxic disease: antioxidant therapy goes from strength to strength
O'Halloran KD, Lewis P
Published Date: 14 July 2017
SNPs, linkage disequilibrium, and chronic mountain sickness in Tibetan Chinese
Buroker NE, Ning XH, Zhou ZN, Li K, Cen WJ, Wu XF, Zhu WZ, Scott CR, Chen SH
Published Date: 14 July 2017
Targeted metabolomics in colorectal cancer: a strategic approach using standardized laboratory tests of the blood and urine
Jerzak KJ, Laureano M, Elsharawi R, Kavsak P, Chan KKW, Dhesy-Thind SK, Zbuk K
Published Date: 24 May 2017
KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation
Lazzari P, Spiga M, Sani M, Zanda M, Fleming IN
Published Date: 23 May 2017
Neuroprotection via RNA-binding protein RBM3 expression is regulated by hypothermia but not by hypoxia in human SK-N-SH neurons
Rosenthal LM, Tong G, Walker C, Wowro SJ, Krech J, Pfitzer C, Justus G, Berger F, Schmitt KR
Published Date: 23 May 2017
A review of the development of tumor vasculature and its effects on the tumor microenvironment
Forster JC, Harriss-Phillips WM, Douglass MJJ, Bezak E
Published Date: 11 April 2017
Update on hypoxia-inducible factors and hydroxylases in oxygen regulatory pathways: from physiology to therapeutics
Ratcliffe P, Koivunen P, Myllyharju J, Ragoussis J, Bovée JV, Batinic-Haberle I, Vinatier C, Trichet V, Robriquet F, Oliver L, Gardie B
Published Date: 15 March 2017
Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer
Seeley TW, Sternlicht MD, Klaus SJ, Neff TB, Liu DY
Published Date: 10 March 2017